869569-99-3

Basic information

• Product Name: BOC-L-4-BR-PHE-NH2
• Synonyms: Boc-Phe(4-Br)-NH2;(2S)-2-(tert-Butoxycarbonylamino)-3-(4-bromophenyl)propanamide;Boc-L-4-Bromophenylalanine amide;Carbamic acid,N-[(1S)-2-amino-1-[(4-bromophenyl)methyl]-2-oxoethyl]-, 1,1-dimethylethyl ester;BOC-L-4-BR-PHE-NH2;VGKNVRSIDINOPV-NSHDSACASA-N
• CAS NO: 869569-99-3
• Molecular Formula: C14H19BrN2O3
• Molecular Weight: 343.219
• Mol File: 869569-99-3.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 526.7 °C at 760 mmHg
• Flash Point: 272.3 °C
• Appearance: /
• Density: 1.367
• CAS DataBase Reference: BOC-L-4-BR-PHE-NH2(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-L-4-BR-PHE-NH2(869569-99-3)
• EPA Substance Registry System: BOC-L-4-BR-PHE-NH2(869569-99-3)

Safety Data

• Hazardous Substances Data: 869569-99-3(Hazardous Substances Data)

Usage

General Description

BOC-L-4-BR-PHE-NH2 is a compound that consists of a BOC (tert-butoxycarbonyl) protecting group, a 4-bromophenyl group, and an amine group. The BOC group is commonly used to protect amine groups in organic synthesis, preventing unwanted reactions and allowing for selective deprotection when needed. The 4-bromophenyl group is a substituted phenyl group with a bromine atom attached, which can impart specific chemical and physical properties to the compound. The amine group is a functional group containing a nitrogen atom bonded to hydrogen atoms, which can participate in various types of chemical reactions. BOC-L-4-BR-PHE-NH2 is likely used in organic synthesis and pharmaceutical research as a building block for the synthesis of more complex molecules.

Upstream product

• 24250-84-8 H-p-BrPhe-OH 
• 24424-99-5 di-tert-butyl dicarbonate 
• 62129-39-9 4-bromo-N-{[(1,1-dimethylethyl)oxy]carbonyl}-L-phenylalanine 
• 99359-33-8 (S)-methyl 2-amino-3-(4-bromophenyl)propanoate 
• 266306-18-7 (S)-3-(4-Bromo-phenyl)-2-tert-butoxycarbonylamino-propionic acid methyl ester 

Relevant articles and documents

OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO

Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein A, B, L, R3, R4, R5, R6, R8, m and n are as defined herein. Such compounds modulate the opioid receptor, particulare the mu-opioid receptor (MOR) and/or the kappa-opioid receptor (KOR), and/or the delta-opioid receptor (DOR). Products containing such compounds, as well as methods for their use and preparation, are also provided.

PEPTIDYL NITRIL COMPOUNDS AS DIPEPTIDYL PEPTIDASE I INHIBITORS

The invention relates to compounds of Formula (I) and its use as a selective dipeptidyl peptidase I inhibitor, as well as pharmaceutical compositions comprising said compounds, and methods of treatment involving said compounds.

N-SUBSTITUTED 3,3'-(BIPHENYL-4,4'-DIYL)BIS-2-AMINOPROPANENITRILES AS DPPI INHIBITORS

The invention relates to a compound of Formula (I) and its use as a selective dipeptidyl peptidase I inhibitor, as well as pharmaceutical compositions comprising said compound, and methods of treatment involving said compounds.